News
-
-
PRESS RELEASE
Evotec joins NURTuRE-AKI consortium to gain multi-omics-based molecular understanding of acute kidney injury
Evotec SE joins NURTuRE-AKI consortium to gain multi-omics-based molecular understanding of acute kidney injury. Initiative aims to develop innovative treatments for AKI patients -
-
-
-
-
-
PRESS RELEASE
Press Release: Riliprubart earns orphan drug designation in the US for antibody-mediated rejection in solid organ transplantation
Sanofi's riliprubart granted orphan drug designation by FDA for antibody-mediated rejection in solid organ transplantation, addressing critical unmet need in transplant medicine -
PRESS RELEASE
U.S. biosimilar specialist Valorum Biologics LLC becomes commercialization partner for Formycon’s Eylea® biosimilar FYB203/AHZANTIVE® (aflibercept-mrbb) in the United States and Canada
Valorum Biologics LLC partners with Formycon AG for commercialization of Eylea biosimilar FYB203/AHZANTIVE in the United States and Canada. Major shareholder ATHOS KG supports financing -
